HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manuel Yepes Selected Research

Coloring Agents (Dyes)

2/2018Polymerase delta-interacting protein 2 deficiency protects against blood-brain barrier permeability in the ischemic brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manuel Yepes Research Topics

Disease

15Ischemic Stroke
12/2018 - 03/2004
14Brain Ischemia (Cerebral Ischemia)
01/2019 - 11/2003
11Stroke (Strokes)
03/2020 - 08/2002
9Ischemia
01/2013 - 08/2002
8Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2013 - 02/2005
7Hypoxia (Hypoxemia)
01/2018 - 10/2009
5Seizures (Absence Seizure)
12/2004 - 06/2002
3Dementia (Dementias)
10/2021 - 06/2002
3Brain Edema (Cerebral Edema)
12/2009 - 08/2002
2Alzheimer Disease (Alzheimer's Disease)
10/2021 - 01/2020
2Inflammation (Inflammations)
04/2021 - 01/2017
2Multiple Sclerosis
06/2007 - 05/2007
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2021
1Insulin Resistance
03/2020
1Cerebral Hemorrhage
10/2017
1Necrosis
01/2017
1Atherosclerosis
01/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2012
1Parkinson Disease (Parkinson's Disease)
02/2010
1Infarction (Infarctions)
02/2010
1Edema (Dropsy)
12/2009
1Neoplasms (Cancer)
10/2009
1Spinal Cord Injuries (Spinal Cord Injury)
05/2009
1Acidosis
03/2008
1Central Nervous System Diseases (CNS Diseases)
05/2007
1Brain Injuries (Brain Injury)
02/2005
1Cardiovascular Diseases (Cardiovascular Disease)
02/2005
1Pneumonia (Pneumonitis)
07/2004
1Familial encephalopathy with neuroserpin inclusion bodies
03/2004
1Ankylosis
07/2003
1Embolic Stroke
08/2002
1Neurologic Manifestations (Neurological Manifestations)
06/2002

Drug/Important Bio-Agent (IBA)

14Tissue Plasminogen Activator (Alteplase)FDA Link
11/2018 - 08/2002
9PlasminogenIBA
10/2021 - 06/2002
8Proteins (Proteins, Gene)FDA Link
12/2015 - 06/2002
6CytokinesIBA
02/2018 - 02/2005
5FibrinolysinFDA Link
01/2022 - 05/2009
5NeuroserpinIBA
11/2010 - 06/2002
3Serine Proteases (Serine Protease)IBA
01/2018 - 05/2009
3Glucose (Dextrose)FDA LinkGeneric
01/2015 - 07/2012
2Amyloid (Amyloid Fibrils)IBA
10/2021 - 01/2020
2Peptide Hydrolases (Proteases)FDA Link
04/2021 - 03/2008
2Plasminogen Activators (Plasminogen Activator)IBA
04/2021 - 12/2018
2Urokinase Plasminogen Activator ReceptorsIBA
01/2019 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
02/2018 - 01/2017
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2018 - 10/2014
2platelet-derived growth factor C (PDGF-C)IBA
10/2017 - 07/2008
2Oxygen (Dioxygen)IBA
01/2012 - 10/2009
2Neuroprotective AgentsIBA
01/2012 - 10/2007
2Kainic Acid (Kainate)IBA
02/2010 - 06/2002
2Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2009 - 01/2009
2Cytokine TWEAKIBA
03/2007 - 02/2005
1Enzyme Precursors (Zymogens)IBA
04/2021
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
03/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018
1Evans Blue (Blue, Evans)FDA Link
02/2018
1Matrix Metalloproteinases (MMPs)IBA
02/2018
1Coloring Agents (Dyes)IBA
02/2018
1ezrinIBA
01/2018
1Platelet-Derived Growth FactorIBA
10/2017
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2017
1Interleukin-12 (IL 12)IBA
01/2017
1Factor XII (Hageman Factor)IBA
01/2017
1ApolipoproteinsIBA
01/2017
1Apolipoproteins E (ApoE)IBA
01/2017
1SpectrinIBA
12/2015
1NeurotoxinsIBA
01/2013
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2012
1Glutamic Acid (Glutamate)FDA Link
06/2011
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
11/2010
16,7-dihydroxyflavoneIBA
02/2010
1Claudin-5IBA
12/2009
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2009
1Transcription Factors (Transcription Factor)IBA
10/2009
1Cyclin D1IBA
09/2009
1Proteinase-Activated ReceptorsIBA
05/2009
1Imatinib Mesylate (Gleevec)FDA Link
07/2008
1Caspase 3 (Caspase-3)IBA
05/2008
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
05/2008
1NF-kappa B (NF-kB)IBA
10/2007
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2007
1LDL Receptors (LDL Receptor)IBA
10/2007
1AntibodiesIBA
06/2007
1LigandsIBA
05/2007
1Immunoglobulin G (IgG)IBA
04/2007
1Cathepsin GIBA
07/2004
1Leukocyte Elastase (Neutrophil Elastase)IBA
07/2004
1Plasminogen Activator Inhibitor 1IBA
07/2004
1EnzymesIBA
07/2004
1Gadolinium DTPA (Magnevist)FDA Link
08/2002

Therapy/Procedure

3Intravenous Administration
11/2018 - 11/2013
2Thrombectomy
12/2018 - 01/2017
2Therapeutics
01/2015 - 10/2009
1Thrombolytic Therapy
10/2017
1Intraventricular Injections
07/2008